drugset / Trial / NCT00251199
VX-950 and Peginterferon for Hepatitis C
RandomizedParallel-groupDouble-blind
Summary
VX-950 is an investigational drug , which is being tested in combination with a known treatment for hepatitis C, peginterferon.
Timeline
- Start
- 2005-10
- Primary completion
- —
- Completion
- 2006-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Telaprevir | Small molecule | — | — |
| Background | Peginterferon alfa-2a | Protein / enzyme biologic | — | — |